先見基因

Always the guardian of your life. 先見基因科技 is committed to precision medicine and aims to usher in a new era of personalized medicine through high-quality, continuously innovative services. Founded in 2014, the company grew out of academic research and carried out technology transfer through industry-academia cooperation with National Cheng Kung University. It continues to specialize in genetic sequencing platform technologies and big data analysis, combining sequencing platforms with customized testing and analysis to meet different research and public market needs. In 2018, it took the lead in bringing the Affymetrix GeneTitan automated multi-locus genotyping array platform from research into the public market. For the first time, an automated platform using an array designed specifically for Asians could test more than 750,000 loci simultaneously. It combines genomic medicine with AI-driven big data analysis to provide precise, rapid genetic testing services.